Recent News
Nintedanib and Pembrolizumab – Hope for Mesothelioma Patients
The latest findings in cancer treatments for the often fatal mesothelioma have scientists and researchers hopeful that they are one step closer in finding a consistent, effective treatment for the[…]
National Asbestos Awareness Week: April 1 – April 7, 2017
On March 29, 2017 the U.S. Senate passed S. Res.98; a resolution designating the first week of April as “National Asbestos Awareness Week” in an attempt to warn and educate[…]
Your Asbestosis Could Lead to Lung Cancer or Mesothelioma
Asbestosis, while not a cancerous condition, is serious and potentially life-threatening chronic disease that is caused by breathing in asbestos fibers. A person who has been diagnosed with asbestosis has[…]
Call Your State Senators to Oppose the Furthering Asbestos Claims Transparency Act
A new bill was approved by the U.S. House Judiciary Committee that could damage the asbestos claims process and prevent victims of asbestos-related diseases from ever seeing any sort of[…]
Nutritional Status and Tumor Thickness Helps Determine Mesothelioma Prognosis
The overall nutritional health of a patient suffering from mesothelioma can have major impact on how the patient will respond to treatment, which affects patient survival. To determine a patient’s[…]
Despite Asbestos Regulations, CDC Reports Increase in Mesothelioma
Mesothelioma is a type of cancer that is specifically caused by asbestos exposure. The cancer affects the lining surrounding various organs and cavities within the body called the mesothelium. Asbestos[…]
Partial Repeal in the ACA Preserves Provisions for Residents in Libby, Montana
The dangers of asbestos have affected thousands of residents in the small town of Libby, Montana for decades. In 1919, the town that was once known for its logging industry[…]
Immunotherapy Drug Tremelimumab Not As Effective As Hoped
Mesothelioma’s aggressive nature makes it difficult to treat with common cancer treatments such as chemotherapy and radiation. Scientists and researchers are constantly looking for new ways to treat mesothelioma outside[…]
The Latest Clinical Trial for Nintedanib – Are You a Candidate?
Scientists and researchers are excited over the latest completion of a Phase II clinical trial for those suffering from mesothelioma – an incurable asbestos-caused cancer that has a median survival[…]
Lack of Treatment Responses for Mesothelioma, Proteins Combat Metastasis
Mesothelioma is an incredibly difficult cancer to treat. Its late stage diagnosis coupled with its aggressive nature leaves victims without very much time to combat this fatal cancer. There are[…]
Skip to content